DENNIS W. BUCK
*** *. ******* *** • Baltimore, MD 21224 • 443-***-**** • ***********@*******.***
SUMMARY
Experienced corporate development specialist seeks the opportunity to help a company grow, both organically and through
M&A. Possesses the knowledge and experience to immediately step in and assist senior management to identify new
business opportunities and execute on their strategic goals.
Negotiation and Structuring of Transactions and Third-party Agreements
Led negotiation and structuring for the following types of corporate transactions:
• Corporate acquisitions, both stock and asset
• Joint ventures
• Co-marketing arrangements
• Product development
• In and out-licensing technology
Financial Valuation & Due Diligence
Extensive experience creating detailed financial models for the valuation and analysis of various assets and businesses
Personally performed financial due diligence on acquisition targets
Led multidisciplinary teams through the due diligence process; including legal, tax, audit, and various internal departments
Experienced in creating detailed financial budgets for newly acquired assets and businesses, including the development of
monthly income statements, balance sheets, and cash flow statements to match the acquiring company’s current operations
Integration
Managed integration teams through various corporate transactions
Led the budgeting process for newly acquired businesses
Performed post-transaction analysis and evaluation
Sourcing
Proven ability to work with internal corporate departments to accomplish strategic goals through the identification of
appropriate partners and products
Identified, contacted, and developed relationships with numerous potential targets through cold-calling, networking, attending
trade-shows and industry events, and establishing relationships with brokers and investment bankers.
Developed multiple databases of potential acquisition targets
Extensive network of professional contacts across various healthcare and chemical manufacturing segments
Strategic Planning
Experience developing short, medium, and long-term strategic plans for achieving corporate growth objectives
Deep understanding of institutional equity investors and their reactions to corporate actions and announcements
Broad Knowledge Base
Experience managing transactions within the healthcare distribution and services, biotechnology, and chemical manufacturing
industries
Analyzed numerous industries and corporations through work in corporate development and with a mutual fund
International Experience
Completed acquisitions, joint ventures, and signed various agreements with companies in Canada, Europe, and Asia
Studied and lived in Geneva, Switzerland, including working as an intern for a U.S. government agency
EXPERIENCE
Global Healthcare Integrators, Washington, DC Jan 2013 –Mar 2015
Director of Business Development
• Working with a team of healthcare professionals to build a specialty drug distribution business for emerging markets.
• Lead the marketing and acquisition of specialty pharmaceutical products for distribution through the company’s
supply chain network.
• Working with potential partners in Hong Kong and Dubai to establish the warehousing and logistics necessary to
transport and deliver biologic products that require special handling and cold storage.
• Provide financial analysis for potential client and investor presentations.
Henry Schein, Inc., Melville, NY Jan 2012 – Dec 2012
Management Associate, Corporate Business Development Group
• Executed the acquisition of a dentist recruitment business, including negotiating the necessary legal documentation,
performing due diligence, and preparing the necessary internal documentation for the approval of the transaction
• Provided valuation analysis, managed due diligence, and provided support for Asia-related acquisitions and joint
ventures, including transactions in Japan, Thailand, and China.
• Provided valuation analysis, managed due diligence, and provided support for specialty dental and dental implant
acquisitions and joint ventures.
• Managed the operating budget for the Corporate Business Development Group, including tracking the costs
associated with all potential and completed acquisitions for the entire group.
• Managed and prepared the submittal of presentations to the Executive Management Committee and the Board of
Directors, detailing each current acquisition that the company was in the process of completing.
• Tracked the performance of past transactions against both projected financials and internal corporate objectives for
regular updates to the Board of Directors and the determination of performance bonus goals.
Asclepius Advisory, LLC, Baltimore, MD Aug 2009 – Dec. 2011
Independent Consultant
• Provided financial consulting and M&A advisory services to healthcare services companies, including institutional
pharmacies and home health agencies.
• Provided valuation services to clients to help them determine their selling strategy.
Synagro Technologies, Inc., Baltimore, MD Mar 2011 – Aug 2011
Contract Consultant
• Assisted senior management in refining the corporate M&A strategy and sourcing potential acquisitions.
• Developed a new valuation model to help streamline the M&A process from initial valuation through the integration
of potential acquisitions.
• Provided valuation analysis and due diligence support for the acquisition of an oil & gas services business, including
the determination of the impact of new employee pay-scale changes and the calculation of employee liabilities assumed
as part of the transaction.
Martek Biosciences Corporation, Columbia, MD Jan 2007 – Apr 2009
Manager, Corporate Development
• Co-led the strategic development of the corporate M&A strategy and led the search for appropriate acquisition and
licensing opportunities both in the U.S. and internationally.
• Constructed detailed financial models for the valuation of potential acquisitions and other internal corporate
projects.
• Worked with internal R&D groups to help them manage relationships with third-party technology providers,
including the negotiation and structuring of third-party agreements to allow for the testing of new products and
technologies.
• Prepared presentations for senior management and the board of directors for the approval of potential acquisitions
and other third-party agreements.
• Negotiated and structured agreement for the co-development and marketing of an encapsulated DHA product with a
European-based company.
• Negotiated a license agreement for an RNAi-based vaccine technology with a major U.S. university in order to
develop a new product line.
Omnicare Inc., Cincinnati, OH Feb 2004 – Jan 2007
Associate, Corporate Development
• Involved in the execution of 22 M&A transactions representing over $2.3 billion in acquired revenue. Duties
included sourcing potential targets, performing valuation analysis, transaction structuring, negotiating deal terms,
managing the due diligence process, overseeing the legal documentation of the transaction, and managing the integration
process.
• Completed 5 acquisitions from initial contact through closing and integration, for businesses ranging from $500,000
to $16 million in acquired revenue each.
• Constructed detailed financial models for the valuation of potential acquisitions and other internal corporate
projects.
• Performed industry research and actively sought out appropriate acquisition opportunities, including the
development of a database containing over 700 potential target companies, the majority of whom are privately owned,
small businesses.
• Prepared and presented presentations for senior management and the board of directors for the approval of potential
acquisitions.
• Managed the production of documentation in response to a second request for information from the Federal Trade
Commission concerning a Hart-Scott-Rodino filing.
Lord, Abbett & Company, Jersey City, NJ Sep 1999 - Jul 2001
Portfolio Assistant, Mid-Cap Value Fund
• Performed attribution and other portfolio performance benchmarking in preparing sales and marketing materials for the
firm and for presentations given by the Portfolio Manager detailing the fund’s methodology.
• Analyzed financial statements and performed company valuations using discounted cash flow models and other
quantitative methods for companies in utility, energy, healthcare, retail, and manufacturing industries.
• Managed relationships and met with company executives and industry analysts to facilitate discussions of specific
company issues and industry trends in the search for investing opportunities.
KPMG LLP, Boston, Massachusetts Aug 1997 - Sep 1999
Research Assistant, Economic Consulting Services
• Provided valuation support in a litigation case in Federal District Court concerning economic damages involving an
electricity generation unit located in Central America.
• Developed proposals for potential clients affected by the deregulation of the electric utility industry in the U.S.
• Determined proper pricing for inter-company transactions under appropriate tax law by utilizing valuation techniques,
including discounted cash flows, comparable company, and comparable transaction analysis.
• Drafted economic reports detailing the restructuring of a major toy corporation for presentation to the client, relevant tax
authorities, and members of KPMG.
EDUCATION
Carnegie Mellon University, Tepper School of Business, Pittsburgh, Pennsylvania Aug 2001 - May 2003
Master of Business Administration (MBA)
Concentrations in Finance, Accounting, and Strategy
Davidson College, Davidson, North Carolina Aug 1994 - May 1997
Bachelor of Arts in Economics
Member of Varsity Soccer Team
Kent State University, Semester Abroad Program, Geneva, Switzerland Jan 1996 - May 1996
Intern with the U.S. Commercial Service